Thanh Hoa pharmaceutical and medical supplies invest in technological innovation

Recently, Thanh Hoa province is one of the localities with a large number of enterprises applying science and technology through cooperation, research and investment. As a result, businesses are increasingly developing, bringing high benefits and getting closer to the market.

Thanh Hoa Pharmaceutical – Medical Material Joint Stock Company is one of the companies in the province that produces and trades in the field of traditional medicines and western medicines. The company always researches and invests in improving the equipment in production. From the renewal of the production line of herbal medicines, Biophin, Hy Dan, and low wind anesthetic to invest in a new production line of automatic soft capsules with Korean technology with a maximum capacity of nearly 700 million capsules / year, and furnace capacity, blister presses, drying system worth over 55 billion.

Thanks to the investment in this new technology line, the Company has helped consolidate the traditional medicine market in the province in the face of strong competition from domestic and foreign enterprises. In parallel with focusing on investment in modern equipment, the Company also focuses on investment in human resources, training scientific staff capable of mastering technology. At the same time, reforming changes the organization of operation models, launching production labor emulation movements, contributing to increasing productivity, improving employee morale as well as building reputation and brand. of the Company on the market.

As a pioneer in researching and applying new science and technology in production, since 2015, the Company has cooperated with Aemed Company of Thailand to establish Aeonmed Vietnam Co., Ltd. The company was established and put the manure solution factory into operation with an investment of more than 3 million USD, a design capacity of 20,000 liters / day. Here are installed modern advanced technology lines, fully automated closed systems and ISO 9001 2008, ISO 13485-2003. The main products of the factory include dialysis solution Haemo A and Haemo B used in hemodialysis for patients with chronic renal failure. In parallel with the investment in modern technology, the Company always attaches great importance to corporate governance to participate in the global supply chain through the Internet to improve competitiveness to stabilize the domestic market and to to export.

With the motto of taking quality as the guideline of all activities, using technology investment to make a difference, the Company has been striving constantly to become one of the 10 largest pharmaceutical enterprises in the country. with a diverse product system, quality, EU GMP standards, to meet the strict requirements of the international pharmaceutical market. To achieve those goals, the Company will continue to research and apply modern science and technology to production to improve product value in the coming time.

Productivity and Quality Office